Drug Database
Back to search

Netherlands· NL-c48dceceba3b

Aripiprazol Teva 10 mg, tabletten

A aripiprazole product containing aripiprazol, registered in Netherlands by Teva Nederland B.V.. The same ATC class is registered in 18 of our 19 countries.

ATC N05AX12

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAripiprazol Teva 10 mg, tablettenATCN05AX12REGISTER NO.NL-c48dceceba3bPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about aripiprazolAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Aripiprazole is registered in 18 of 19 countries.

Countries holding a registration under ATC N05AX12 (aripiprazole), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 11 of them publish a price we can compare per daily dose
Search aripiprazole products by name

Aripiprazole · ATC N05AX12

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of aripiprazole costs, country by country.

Normalised to the WHO defined daily dose (15 mg), the median price runs from $0.15 in United States to $3.12 in Switzerland — a ×21 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Aripiprazole · price per daily dose (15 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.12
  • IT Italy$1.19
  • FR France$1.06
  • US United States$0.15 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ARIPIPRAZOL
Manufacturer
Teva Nederland B.V.
Country
Netherlands (NL)
ATC code
N05AX12
ATC class
Aripiprazole
Defined daily dose
15 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    115599

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

468 interactions on record for aripiprazole.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check aripiprazole against other medicinesHow interaction checks work

Aripiprazole · interactions on record

468 records

  • 11 severe
  • 339 moderate
  • 2 minor
  • 67 info

Most severe, free to view

  • MetoclopramideA03FA01severe
  • ClotrimazoleA01AB18moderate
  • CimetidineA02BA01moderate
  • FamotidineA02BA03moderate

49 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under N05AX12

Aripiprazole, as other registers publish it.

All aripiprazole products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ff0c564d-45fd-4af0-a3be-9c9f770f2dde
GET /v1/drugs/ff0c564d-45fd-4af0-a3be-9c9f770f2dde?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h115599_smpc.pdf",
  "strength": null,
  "atc_label": "Aripiprazole",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg115599",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROLOSE (E 463)",
    "IJZEROXIDE ROOD  (E 172)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL"
  ],
  "substances": [
    "ARIPIPRAZOL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h115599.pdf",
  "authorised_at": "2015/04/30",
  "procedure_number": "DE/H/5039/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "115599",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about aripiprazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console